Loading…

Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors

Regenerating large bone defects remains a significant clinical challenge, motivating increased interest in additive manufacturing and 3D bioprinting to engineer superior bone graft substitutes. 3D bioprinting enables different biomaterials, cell types, and growth factors to be combined to develop pa...

Full description

Saved in:
Bibliographic Details
Published in:Trends in molecular medicine 2021-07, Vol.27 (7), p.700-711
Main Authors: Freeman, Fiona E., Burdis, Ross, Kelly, Daniel J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-5bc9e5f62c02efe5ac10ba757440b1bdee0f696215e379a6e93bd27a902773e53
cites cdi_FETCH-LOGICAL-c408t-5bc9e5f62c02efe5ac10ba757440b1bdee0f696215e379a6e93bd27a902773e53
container_end_page 711
container_issue 7
container_start_page 700
container_title Trends in molecular medicine
container_volume 27
creator Freeman, Fiona E.
Burdis, Ross
Kelly, Daniel J.
description Regenerating large bone defects remains a significant clinical challenge, motivating increased interest in additive manufacturing and 3D bioprinting to engineer superior bone graft substitutes. 3D bioprinting enables different biomaterials, cell types, and growth factors to be combined to develop patient-specific implants capable of directing functional bone regeneration. Current approaches to bioprinting such implants fall into one of two categories, each with their own advantages and limitations. First are those that can be 3D bioprinted and then directly implanted into the body and second those that require further in vitro culture after bioprinting to engineer more mature tissues prior to implantation. This review covers the key concepts, challenges, and applications of both strategies to regenerate damaged and diseased bone. 3D bioprinting strategies generally fall under two categories, herein defined as either print-and-implant approaches or those that require further in vitro maturation post-printing to create engineered tissues.By combining ceramics and synthetic polymers, researchers are able to generate osteoinductive implants with mechanical properties compatible with implantation into load-bearing environments.Using 3D bioprinting to deliver growth factors in a spatiotemporal manner that mimics the natural healing cascade can significantly enhance bone regeneration.Endothelialised 3D printed channels have been shown to anastomose with host vasculature following implantation.Bioprinted avascular cartilage templates can induce endochondral bone formation in vivo.3D bioprinting of scaffold-free tissues has emerged as potential new strategy for the engineering of functional tissues.
doi_str_mv 10.1016/j.molmed.2021.05.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2538052249</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1471491421001209</els_id><sourcerecordid>2538052249</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-5bc9e5f62c02efe5ac10ba757440b1bdee0f696215e379a6e93bd27a902773e53</originalsourceid><addsrcrecordid>eNp9kE1PxCAURYnR-P0PjOnSTeuDQhlcmPityURdqHFHKH01TKZlhM4Y_72Moy5dQXLP5fEOIQcUCgq0Op4UnZ922BQMGC1AFAB0jWxTLmnOlXpd_7tTvkV2YpwkQEg52iRbJQcFI1Db5OUxuH5w_Vt2jx_Zue8xnmTXwXfZd5CbvsnvutnU9EN2iQtnMWaDz86dny1zbL472UN4M32qoJ2H6EPcIxutmUbc_zl3yfP11dPFbT5-uLm7OBvnlsNoyEVtFYq2YhYYtiiMpVAbKSTnUNO6QYS2UhWjAkupTIWqrBsmjQImZYmi3CVHq3dnwb_PMQ66c9HiNP0X_TxqJsoRCMa4SihfoTb4GAO2Om3QmfCpKeilUT3RK6N6aVSD0ElYqh3-TJjXy-y39KswAacrANOeC4dBR-uwt9i4pGPQjXf_T_gCMECI0w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2538052249</pqid></control><display><type>article</type><title>Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors</title><source>Elsevier</source><creator>Freeman, Fiona E. ; Burdis, Ross ; Kelly, Daniel J.</creator><creatorcontrib>Freeman, Fiona E. ; Burdis, Ross ; Kelly, Daniel J.</creatorcontrib><description>Regenerating large bone defects remains a significant clinical challenge, motivating increased interest in additive manufacturing and 3D bioprinting to engineer superior bone graft substitutes. 3D bioprinting enables different biomaterials, cell types, and growth factors to be combined to develop patient-specific implants capable of directing functional bone regeneration. Current approaches to bioprinting such implants fall into one of two categories, each with their own advantages and limitations. First are those that can be 3D bioprinted and then directly implanted into the body and second those that require further in vitro culture after bioprinting to engineer more mature tissues prior to implantation. This review covers the key concepts, challenges, and applications of both strategies to regenerate damaged and diseased bone. 3D bioprinting strategies generally fall under two categories, herein defined as either print-and-implant approaches or those that require further in vitro maturation post-printing to create engineered tissues.By combining ceramics and synthetic polymers, researchers are able to generate osteoinductive implants with mechanical properties compatible with implantation into load-bearing environments.Using 3D bioprinting to deliver growth factors in a spatiotemporal manner that mimics the natural healing cascade can significantly enhance bone regeneration.Endothelialised 3D printed channels have been shown to anastomose with host vasculature following implantation.Bioprinted avascular cartilage templates can induce endochondral bone formation in vivo.3D bioprinting of scaffold-free tissues has emerged as potential new strategy for the engineering of functional tissues.</description><identifier>ISSN: 1471-4914</identifier><identifier>EISSN: 1471-499X</identifier><identifier>DOI: 10.1016/j.molmed.2021.05.001</identifier><identifier>PMID: 34090809</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; bioprinting ; Bioprinting - instrumentation ; bone and bones ; Bone and Bones - cytology ; Bone Regeneration ; Humans ; Printing, Three-Dimensional - instrumentation ; tissue engineering ; Tissue Engineering - methods ; Tissue Scaffolds - chemistry ; Wound Healing</subject><ispartof>Trends in molecular medicine, 2021-07, Vol.27 (7), p.700-711</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-5bc9e5f62c02efe5ac10ba757440b1bdee0f696215e379a6e93bd27a902773e53</citedby><cites>FETCH-LOGICAL-c408t-5bc9e5f62c02efe5ac10ba757440b1bdee0f696215e379a6e93bd27a902773e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34090809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Freeman, Fiona E.</creatorcontrib><creatorcontrib>Burdis, Ross</creatorcontrib><creatorcontrib>Kelly, Daniel J.</creatorcontrib><title>Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors</title><title>Trends in molecular medicine</title><addtitle>Trends Mol Med</addtitle><description>Regenerating large bone defects remains a significant clinical challenge, motivating increased interest in additive manufacturing and 3D bioprinting to engineer superior bone graft substitutes. 3D bioprinting enables different biomaterials, cell types, and growth factors to be combined to develop patient-specific implants capable of directing functional bone regeneration. Current approaches to bioprinting such implants fall into one of two categories, each with their own advantages and limitations. First are those that can be 3D bioprinted and then directly implanted into the body and second those that require further in vitro culture after bioprinting to engineer more mature tissues prior to implantation. This review covers the key concepts, challenges, and applications of both strategies to regenerate damaged and diseased bone. 3D bioprinting strategies generally fall under two categories, herein defined as either print-and-implant approaches or those that require further in vitro maturation post-printing to create engineered tissues.By combining ceramics and synthetic polymers, researchers are able to generate osteoinductive implants with mechanical properties compatible with implantation into load-bearing environments.Using 3D bioprinting to deliver growth factors in a spatiotemporal manner that mimics the natural healing cascade can significantly enhance bone regeneration.Endothelialised 3D printed channels have been shown to anastomose with host vasculature following implantation.Bioprinted avascular cartilage templates can induce endochondral bone formation in vivo.3D bioprinting of scaffold-free tissues has emerged as potential new strategy for the engineering of functional tissues.</description><subject>Animals</subject><subject>bioprinting</subject><subject>Bioprinting - instrumentation</subject><subject>bone and bones</subject><subject>Bone and Bones - cytology</subject><subject>Bone Regeneration</subject><subject>Humans</subject><subject>Printing, Three-Dimensional - instrumentation</subject><subject>tissue engineering</subject><subject>Tissue Engineering - methods</subject><subject>Tissue Scaffolds - chemistry</subject><subject>Wound Healing</subject><issn>1471-4914</issn><issn>1471-499X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PxCAURYnR-P0PjOnSTeuDQhlcmPityURdqHFHKH01TKZlhM4Y_72Moy5dQXLP5fEOIQcUCgq0Op4UnZ922BQMGC1AFAB0jWxTLmnOlXpd_7tTvkV2YpwkQEg52iRbJQcFI1Db5OUxuH5w_Vt2jx_Zue8xnmTXwXfZd5CbvsnvutnU9EN2iQtnMWaDz86dny1zbL472UN4M32qoJ2H6EPcIxutmUbc_zl3yfP11dPFbT5-uLm7OBvnlsNoyEVtFYq2YhYYtiiMpVAbKSTnUNO6QYS2UhWjAkupTIWqrBsmjQImZYmi3CVHq3dnwb_PMQ66c9HiNP0X_TxqJsoRCMa4SihfoTb4GAO2Om3QmfCpKeilUT3RK6N6aVSD0ElYqh3-TJjXy-y39KswAacrANOeC4dBR-uwt9i4pGPQjXf_T_gCMECI0w</recordid><startdate>202107</startdate><enddate>202107</enddate><creator>Freeman, Fiona E.</creator><creator>Burdis, Ross</creator><creator>Kelly, Daniel J.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202107</creationdate><title>Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors</title><author>Freeman, Fiona E. ; Burdis, Ross ; Kelly, Daniel J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-5bc9e5f62c02efe5ac10ba757440b1bdee0f696215e379a6e93bd27a902773e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>bioprinting</topic><topic>Bioprinting - instrumentation</topic><topic>bone and bones</topic><topic>Bone and Bones - cytology</topic><topic>Bone Regeneration</topic><topic>Humans</topic><topic>Printing, Three-Dimensional - instrumentation</topic><topic>tissue engineering</topic><topic>Tissue Engineering - methods</topic><topic>Tissue Scaffolds - chemistry</topic><topic>Wound Healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Freeman, Fiona E.</creatorcontrib><creatorcontrib>Burdis, Ross</creatorcontrib><creatorcontrib>Kelly, Daniel J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Freeman, Fiona E.</au><au>Burdis, Ross</au><au>Kelly, Daniel J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors</atitle><jtitle>Trends in molecular medicine</jtitle><addtitle>Trends Mol Med</addtitle><date>2021-07</date><risdate>2021</risdate><volume>27</volume><issue>7</issue><spage>700</spage><epage>711</epage><pages>700-711</pages><issn>1471-4914</issn><eissn>1471-499X</eissn><abstract>Regenerating large bone defects remains a significant clinical challenge, motivating increased interest in additive manufacturing and 3D bioprinting to engineer superior bone graft substitutes. 3D bioprinting enables different biomaterials, cell types, and growth factors to be combined to develop patient-specific implants capable of directing functional bone regeneration. Current approaches to bioprinting such implants fall into one of two categories, each with their own advantages and limitations. First are those that can be 3D bioprinted and then directly implanted into the body and second those that require further in vitro culture after bioprinting to engineer more mature tissues prior to implantation. This review covers the key concepts, challenges, and applications of both strategies to regenerate damaged and diseased bone. 3D bioprinting strategies generally fall under two categories, herein defined as either print-and-implant approaches or those that require further in vitro maturation post-printing to create engineered tissues.By combining ceramics and synthetic polymers, researchers are able to generate osteoinductive implants with mechanical properties compatible with implantation into load-bearing environments.Using 3D bioprinting to deliver growth factors in a spatiotemporal manner that mimics the natural healing cascade can significantly enhance bone regeneration.Endothelialised 3D printed channels have been shown to anastomose with host vasculature following implantation.Bioprinted avascular cartilage templates can induce endochondral bone formation in vivo.3D bioprinting of scaffold-free tissues has emerged as potential new strategy for the engineering of functional tissues.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34090809</pmid><doi>10.1016/j.molmed.2021.05.001</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-4914
ispartof Trends in molecular medicine, 2021-07, Vol.27 (7), p.700-711
issn 1471-4914
1471-499X
language eng
recordid cdi_proquest_miscellaneous_2538052249
source Elsevier
subjects Animals
bioprinting
Bioprinting - instrumentation
bone and bones
Bone and Bones - cytology
Bone Regeneration
Humans
Printing, Three-Dimensional - instrumentation
tissue engineering
Tissue Engineering - methods
Tissue Scaffolds - chemistry
Wound Healing
title Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T17%3A09%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Printing%20New%20Bones:%20From%20Print-and-Implant%20Devices%20to%20Bioprinted%20Bone%20Organ%20Precursors&rft.jtitle=Trends%20in%20molecular%20medicine&rft.au=Freeman,%20Fiona%20E.&rft.date=2021-07&rft.volume=27&rft.issue=7&rft.spage=700&rft.epage=711&rft.pages=700-711&rft.issn=1471-4914&rft.eissn=1471-499X&rft_id=info:doi/10.1016/j.molmed.2021.05.001&rft_dat=%3Cproquest_cross%3E2538052249%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-5bc9e5f62c02efe5ac10ba757440b1bdee0f696215e379a6e93bd27a902773e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2538052249&rft_id=info:pmid/34090809&rfr_iscdi=true